Suzhou Fushilai Pharmaceutical (301258.SZ) Obtains European CEP Certificate for Active Pharmaceutical Ingredients
Fosun Pharma (301258.SZ) announcement, the company has received a notification from the European Medicines Agency (EMA) regarding...
Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company has received the Certificate of Suitability (CEP) for the European Pharmacopoeia for the raw material drug Lipoic Acid issued by the European Directorate for Quality Medicines (EDQM). The manufacturer of Lipoic Acid is STADA in Germany, a compound belonging to the vitamin category, mainly used for diabetic polyneuropathy.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
